role cancer immunotherapi arena cellular immunotherapi field studi field strong foundat numer anim tumor model avenu research refin human immunotherapi experi number research center lak cell trial human pbmc possess reproduc antitumor activ vitro exogen administr patient biolog activ activ cell requir lak cell tumor melanoma clear-cut overal respons rate human toxic immunotherapi dose system next gener trial cellular immunotherapi human til murin experi popul cell power specif tumor lak cell lak cell til exogen optimum perform vivo difficulti reproduc til growth use monoclon antibodi activ improv til therapi use til hybrid antibodi addit biolog respons modifi implement cell cell product 